Skip to content
Recall Observatory FDA recall evidence

Drug product

Amlodipine Besylate and Benazepril HCl Capsules, 5 mg/10 mg, packaged in a) 100-count bottles (NDC 0378-6896-01) and b) 500-count bottles (NDC 0378-6896-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

D-66403-006

September 13, 2013

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 66403
Status
Terminated
Classification
Class II
Quantity
30,878 bottles
Official record key
drug-enforcement:D-66403-006

Official wording

Reason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Code information: Lot #: a) 2003159, 2003160, 2003161, 3043492; b) 2003158, 2003159, 3043492

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations